BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Monaco S, Mariotto S, Ferrari S, Calabrese M, Zanusso G, Gajofatto A, Sansonno D, Dammacco F. Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015. World J Gastroenterol 2015; 21(42): 11974-11983 [PMID: 26576086 DOI: 10.3748/wjg.v21.i42.11974] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 52] [Article Influence: 8.9] [Reference Citation Analysis]
Number Citing Articles
1 Forton DM. Hepatitis C - the brain strain. Liver Int 2016;36:1415-7. [PMID: 27616335 DOI: 10.1111/liv.13162] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Zhang XH, Shi JY, Zhan C, Zhang L, Chen HJ. Intrinsic Brain Abnormalities in Patients with Hepatitis C Virus Infection with Cognitive Impairment: A Preliminary Resting-State fMRI Study. Biomed Res Int 2020;2020:1693043. [PMID: 33204682 DOI: 10.1155/2020/1693043] [Reference Citation Analysis]
3 Mohamed HM, Mahmoud AM. Chronic exposure to the opioid tramadol induces oxidative damage, inflammation and apoptosis, and alters cerebral monoamine neurotransmitters in rats. Biomedicine & Pharmacotherapy 2019;110:239-47. [DOI: 10.1016/j.biopha.2018.11.141] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
4 Weinstein AA, Estep JM, de Avila L, Curry M, Golabi P, Escheik C, Birerdinc A, Stepanova M, Price JK, Gerber L, Younossi ZM. Relationships among neurotransmitters, cytokines and cognitive performance for individuals with hepatitis C achieving sustained virologic response: A pilot study. J Neuroimmunol 2019;335:577022. [PMID: 31445380 DOI: 10.1016/j.jneuroim.2019.577022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
5 Bentes AA, Maia De Castro Romanelli R, Crispim APC, Marinho PES, Loutfi KS, Araujo ST, Campos E Silva LM, Guedes I, Martins Alvarenga A, Santos MA, Geessien Kroon E. Neurological manifestations due to dengue virus infection in children: clinical follow-up. Pathog Glob Health 2021;:1-7. [PMID: 34223795 DOI: 10.1080/20477724.2021.1942680] [Reference Citation Analysis]
6 Santos-Lima C, Souza-Marques B, Vieira F, Isabel Schinoni M, Quarantini LC, Abreu N. Neuropsychological effects of direct-acting antiviral treatment for Hepatitis C virus subjects: A systematic review. J Viral Hepat 2021. [PMID: 34320255 DOI: 10.1111/jvh.13584] [Reference Citation Analysis]
7 Mapoure NY, Budzi MN, Eloumou SAFB, Malongue A, Okalla C, Luma HN. Neurological manifestations in chronic hepatitis C patients receiving care in a reference hospital in sub-Saharan Africa: A cross-sectional study. PLoS One. 2018;13:e0192406. [PMID: 29513678 DOI: 10.1371/journal.pone.0192406] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
8 Shah NM, Malhotra AM, Kaltsakas G. Sleep disorder in patients with chronic liver disease: a narrative review. J Thorac Dis 2020;12:S248-60. [PMID: 33214928 DOI: 10.21037/jtd-cus-2020-012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
9 Studaway A, Ojha RP, Brinkman TM, Zhang N, Baassiri M, Banerjee P, Ehrhardt MJ, Srivastava D, Robison LL, Hudson MM, Krull KR. Chronic hepatitis C virus infection and neurocognitive function in adult survivors of childhood cancer. Cancer 2017;123:4498-505. [PMID: 28743159 DOI: 10.1002/cncr.30913] [Reference Citation Analysis]
10 Corgiolu S, Barberini L, Suri JS, Mandas A, Costaggiu D, Piano P, Zaccagna F, Lucatelli P, Balestrieri A, Saba L. Resting-state functional connectivity MRI analysis in Human Immunodeficiency Virus and Hepatitis C Virus co-infected subjects. A pilot study. Eur J Radiol 2018;102:220-7. [PMID: 29685540 DOI: 10.1016/j.ejrad.2018.03.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
11 Hegab DS, Sweilam MA. Cryoglobulinaemia in Egyptian Patients with Extrahepatic Cutaneous Manifestations of Chronic Hepatitis C Virus Infection. Dermatol Res Pract 2015;2015:182609. [PMID: 26839534 DOI: 10.1155/2015/182609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
12 Zignego AL, Ramos-Casals M, Ferri C, Saadoun D, Arcaini L, Roccatello D, Antonelli A, Desbois AC, Comarmond C, Gragnani L, Casato M, Lamprecht P, Mangia A, Tzioufas AG, Younossi ZM, Cacoub P; ISG-EHCV. International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement. Autoimmun Rev. 2017;16:523-541. [PMID: 28286108 DOI: 10.1016/j.autrev.2017.03.004] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 10.4] [Reference Citation Analysis]
13 Wijarnpreecha K, Chesdachai S, Jaruvongvanich V, Ungprasert P. Hepatitis C virus infection and risk of Parkinson's disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2018;30:9-13. [PMID: 29049127 DOI: 10.1097/MEG.0000000000000991] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
14 Nevola R, Rinaldi L, Zeni L, Romano C, Marrone A, Galiero R, Pafundi PC, Acierno C, Vetrano E, Adinolfi LE. Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals. Expert Rev Gastroenterol Hepatol 2021;15:643-56. [PMID: 33445990 DOI: 10.1080/17474124.2021.1877136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Squarza S, Galli A, Cariati M, Alberici F, Bertolini V, Frediani F, Uggetti C. Magnetic resonance imaging in central nervous system vasculitis in a patient affected by crioglobulin-negative hepatitis C virus infection: A likely correlation. Neuroradiol J 2018;31:193-5. [PMID: 28735554 DOI: 10.1177/1971400917700437] [Reference Citation Analysis]
16 Lorkiewicz SA, Ventura AS, Heeren TC, Winter MR, Walley AY, Sullivan M, Samet JH, Saitz R. Lifetime marijuana and alcohol use, and cognitive dysfunction in people with human immunodeficiency virus infection. Subst Abus 2018;39:116-23. [PMID: 29058572 DOI: 10.1080/08897077.2017.1391925] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
17 Pol S, Vallet-Pichard A, Hermine O. Extrahepatic cancers and chronic HCV infection. Nat Rev Gastroenterol Hepatol. 2018;15:283-290. [PMID: 29339810 DOI: 10.1038/nrgastro.2017.172] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
18 Tsai PC, Chen CY, Kuo HT, Hung CH, Tseng KC, Lai HC, Peng CY, Wang JH, Chen JJ, Lee PL, Chien RN, Yang CC, Lo GH, Kao JH, Liu CJ, Liu CH, Yan SL, Bair MJ, Lin CY, Su WW, Chu CH, Chen CJ, Tung SY, Tai CM, Lin CW, Lo CC, Cheng PN, Chiu YC, Wang CC, Cheng JS, Tsai WL, Lin HC, Huang YH, Yeh ML, Huang CF, Hsieh MH, Huang JF, Dai CY, Chung WL, Ke CK, Yu ML. Successful Antiviral Therapy Reduces Risk of Schizophrenia Among Chronic Hepatitis C Patients: A Nationwide Real-World Taiwanese Cohort (T-COACH). Open Forum Infect Dis 2020;7:ofaa397. [PMID: 33376753 DOI: 10.1093/ofid/ofaa397] [Reference Citation Analysis]
19 Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S. Effect of Sarcopenia on Sleep Disturbance in Patients with Chronic Liver Diseases. J Clin Med 2018;8:E16. [PMID: 30583494 DOI: 10.3390/jcm8010016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
20 Golabi P, Otgonsuren M, Sayiner M, Arsalla A, Gogoll T, Younossi ZM. The Prevalence of Parkinson Disease Among Patients With Hepatitis C Infection. Annals of Hepatology 2017;16:342-8. [DOI: 10.5604/01.3001.0009.8588] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Carvalho TL, Mertens Brainer de Queiroz Lima AC, de Araújo NS, de Sousa Fernandes MS, Lira GB, de Melo MMM, Vasconcelos LRS, de Moura PMMF, da Cunha Correia C. Aspects of cognitive assessments and spectroscopic magnetic resonance imaging in people with chronic hepatitis C: a systematic review. Psychol Health Med 2022;:1-17. [PMID: 35075963 DOI: 10.1080/13548506.2022.2029915] [Reference Citation Analysis]
22 Loftis JM, Valerio J, Taylor J, Huang E, Hudson R, Taylor-Young P, Chang M, Ho SB, Dieperink E, Miranda JL, Hauser P. S100B and Inflammatory Cytokine Levels in Blood as Potential Markers of Blood-Brain Barrier Damage and Psychiatric Impairment in Comorbid Hepatitis C Viral Infection and Alcohol Use Disorder. Alcohol Clin Exp Res 2018. [PMID: 29953169 DOI: 10.1111/acer.13796] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
23 Dammacco F, Lauletta G, Russi S, Leone P, Tucci M, Manno C, Monaco S, Ferrari S, Vacca A, Racanelli V. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis. Clin Exp Med. 2019;19:1-21. [PMID: 30430284 DOI: 10.1007/s10238-018-0536-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
24 Roccatello D, Saadoun D, Ramos-Casals M, Tzioufas AG, Fervenza FC, Cacoub P, Zignego AL, Ferri C. Cryoglobulinaemia. Nat Rev Dis Primers 2018;4:11. [PMID: 30072738 DOI: 10.1038/s41572-018-0009-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 13.8] [Reference Citation Analysis]
25 Kesen O, Kani HT, Yanartaş Ö, Aykut UE, Gök B, Gündüz F, Yılmaz Y, Özdoğan OC, Özen Alahdab Y. Evaluation of depression, anxiety and quality of life in hepatitis C patients who treated with direct acting antiviral agents. Turk J Gastroenterol 2019;30:801-6. [PMID: 31530524 DOI: 10.5152/tjg.2019.18679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Tagliapietra M, Monaco S. Neuroimaging Findings in Chronic Hepatitis C Virus Infection: Correlation with Neurocognitive and Neuropsychiatric Manifestations. Int J Mol Sci. 2020;21. [PMID: 32252497 DOI: 10.3390/ijms21072478] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 Lin HC, Xirasagar S, Lee HC, Huang CC, Chen CH. Association of Alzhemier's disease with hepatitis C among patients with bipolar disorder. PLoS One 2017;12:e0179312. [PMID: 28622343 DOI: 10.1371/journal.pone.0179312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
28 Evon DM, Stewart PW, Amador J, Serper M, Lok AS, Sterling RK, Sarkar S, Golin CE, Reeve BB, Nelson DR, Reau N, Lim JK, Reddy KR, Di Bisceglie AM, Fried MW. . A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study. PLoS One. 2018;13:e0196908. [PMID: 30067745 DOI: 10.1371/journal.pone.0196908] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
29 Ibáñez-Samaniego L, Rapado-Castro M, Cabrero L, Navarrete C, García-Mulas S, Ahumada A, Marquez L, Pérez MD, Rincon D, Bañares R, Garcia-Martinez R. Hepatitis C eradication improves cognitive function in patients with or without cirrhosis: A prospective real-life study. Eur J Neurol 2021. [PMID: 34634159 DOI: 10.1111/ene.15138] [Reference Citation Analysis]
30 Abutaleb A, Kattakuzhy S, Kottilil S, O'Connor E, Wilson E. Mechanisms of neuropathogenesis in HIV and HCV: similarities, differences, and unknowns. J Neurovirol 2018;24:670-8. [PMID: 30291565 DOI: 10.1007/s13365-018-0678-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Barreira DP, Marinho RT, Bicho M, Flores I, Fialho R, Ouakinin S. Hepatitis C Pretreatment Profile and Gender Differences: Cognition and Disease Severity Effects. Front Psychol 2019;10:2317. [PMID: 31681109 DOI: 10.3389/fpsyg.2019.02317] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
32 Marino A, Scuderi D, Locatelli ME, Gentile A, Pampaloni A, Cosentino F, Ceccarelli M, Celesia BM, Benanti F, Nunnari G, Montineri A, Cacopardo B. Modification of Serum Brain-Derived Neurotrophic Factor Levels Following Anti-HCV Therapy with Direct Antiviral Agents: A New Marker of Neurocognitive Disorders. Hepat Mon 2020;20. [DOI: 10.5812/hepatmon.95101] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Abrantes J, Torres DS, Brandão-Mello CE. The Many Difficulties and Subtleties in the Cognitive Assessment of Chronic Hepatitis C Infection. Int J Hepatol 2020;2020:9675235. [PMID: 32257447 DOI: 10.1155/2020/9675235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Ferri C, Ramos-Casals M, Zignego AL, Arcaini L, Roccatello D, Antonelli A, Saadoun D, Desbois AC, Sebastiani M, Casato M. International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement. Autoimmun Rev. 2016;15:1145-1160. [PMID: 27640316 DOI: 10.1016/j.autrev.2016.09.006] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 10.5] [Reference Citation Analysis]
35 Fagiuoli S, Caporaso N, Morisco F, Buelli F, Gualberti G, Saragaglia V, Chessa L, Corti G, Maida I, Mastroianni CM, Pirisi M, Russo FP, Farina F, Giannitrapani L, Toniutto P, Tarquini P, Tundo P, Vecchiet J, Vinci M, Taliani G; HepaDisk Study Group. HepaDisk - A new quality of life questionnaire for HCV patients. Dig Liver Dis 2019;51:1008-15. [PMID: 30661988 DOI: 10.1016/j.dld.2018.12.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
36 Ichikawa T, Miyaaki H, Miuma S, Taura N, Motoyoshi Y, Akahoshi H, Nakamura S, Nakamura J, Takahashi Y, Honda T, Yajima H, Uehara R, Hino N, Narita S, Tanaka H, Sasaki S, Nakao K. Hepatitis C virus-related symptoms, but not quality of life, were improved by treatment with direct-acting antivirals: HCV symptoms after antivirals. Hepatol Res 2018;48:E232-9. [DOI: 10.1111/hepr.12974] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
37 Besedovsky L, Lange T, Haack M. The Sleep-Immune Crosstalk in Health and Disease. Physiol Rev 2019;99:1325-80. [PMID: 30920354 DOI: 10.1152/physrev.00010.2018] [Cited by in Crossref: 198] [Cited by in F6Publishing: 176] [Article Influence: 66.0] [Reference Citation Analysis]
38 Goutzamanis S, Doyle J, Higgs P, Hellard M. Improving hepatitis C direct-acting antiviral access and uptake: A role for patient-reported outcomes and lived experience. J Viral Hepat 2019;26:218-23. [PMID: 30315689 DOI: 10.1111/jvh.13020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
39 Dammacco F, Racanelli V, Russi S, Sansonno D. The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review. Clin Exp Med 2016;16:233-42. [PMID: 26935415 DOI: 10.1007/s10238-016-0410-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
40 Barreira DP, Marinho RT, Bicho M, Fialho R, Ouakinin SRS. Psychosocial and Neurocognitive Factors Associated With Hepatitis C - Implications for Future Health and Wellbeing. Front Psychol 2018;9:2666. [PMID: 30687151 DOI: 10.3389/fpsyg.2018.02666] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
41 Retamozo S, Brito-Zerón P, Quartuccio L, De Vita S, Ramos-Casals M. Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection. Expert Rev Clin Pharmacol 2017;10:1085-101. [PMID: 28715943 DOI: 10.1080/17512433.2017.1357466] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
42 Ramos-casals M, Zignego AL, Ferri C, Brito-zerón P, Retamozo S, Casato M, Lamprecht P, Mangia A, Saadoun D, Tzioufas AG, Younossi ZM, Cacoub P. Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection. Journal of Hepatology 2017;66:1282-99. [DOI: 10.1016/j.jhep.2017.02.010] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 10.2] [Reference Citation Analysis]
43 Vaghi G, Gori B, Strigaro G, Burlone M, Minisini R, Barbaglia MN, Brigatti E, Varrasi C, Pirisi M, Cantello R. Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study. J Neurovirol. 2020;26:870-879. [PMID: 32910431 DOI: 10.1007/s13365-020-00904-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
44 Younossi ZM, Birerdinc A, Henry L. Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences. Journal of Hepatology 2016;65:S109-19. [DOI: 10.1016/j.jhep.2016.07.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 7.2] [Reference Citation Analysis]
45 Amirsardari Z, Rahmani F, Rezaei N. Cognitive impairments in HCV infection: From pathogenesis to neuroimaging. J Clin Exp Neuropsychol 2019;41:987-1000. [PMID: 31405320 DOI: 10.1080/13803395.2019.1652728] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
46 Younossi ZM, Stepanova M, Feld J, Zeuzem S, Jacobson I, Agarwal K, Hezode C, Nader F, Henry L, Hunt S. Sofosbuvir/velpatasvir improves patient-reported outcomes in HCV patients: Results from ASTRAL-1 placebo-controlled trial. J Hepatol. 2016;65:33-39. [PMID: 26956698 DOI: 10.1016/j.jhep.2016.02.042] [Cited by in Crossref: 80] [Cited by in F6Publishing: 74] [Article Influence: 13.3] [Reference Citation Analysis]
47 Esmael A, Belal T, Amer IF, Samra E, Elmongui A, Shawki S. Predictive value of P300 event-related potential component in early cognitive impairment in patients with uncomplicated newly diagnosed hepatitis C virus. Egypt J Neurol Psychiatry Neurosurg 2022;58. [DOI: 10.1186/s41983-022-00450-4] [Reference Citation Analysis]
48 Golabi P, Elsheikh E, Karrar A, Estep JM, Younossi I, Stepanova M, Gerber L, Younossi ZM. The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV). Medicine (Baltimore). 2016;95:e5066. [PMID: 27861337 DOI: 10.1097/md.0000000000005066] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
49 Juanbeltz R, Martínez-Baz I, San Miguel R, Goñi-Esarte S, Cabasés JM, Castilla J. Impact of successful treatment with direct-acting antiviral agents on health-related quality of life in chronic hepatitis C patients. PLoS One 2018;13:e0205277. [PMID: 30300395 DOI: 10.1371/journal.pone.0205277] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
50 Scheiner B, Schwabl P, Steiner S, Bucsics T, Chromy D, Aichelburg MC, Grabmeier-Pfistershammer K, Trauner M, Peck-Radosavljevic M, Reiberger T, Mandorfer M. Interferon-free regimens improve health-related quality of life and fatigue in HIV/HCV-coinfected patients with advanced liver disease: A retrospective study. Medicine (Baltimore) 2016;95:e4061. [PMID: 27399090 DOI: 10.1097/MD.0000000000004061] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
51 Calcagno A, Di Perri G, Bonora S. Treating HIV Infection in the Central Nervous System. Drugs 2017;77:145-57. [PMID: 28070871 DOI: 10.1007/s40265-016-0678-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
52 Formentin C, Garrido M, Montagnese S. Assessment and Management of Sleep Disturbance in Cirrhosis. Curr Hepatol Rep 2018;17:52-69. [PMID: 29876197 DOI: 10.1007/s11901-018-0390-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]